anthrone has been researched along with Psoriasis in 4 studies
*Psoriasis: A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis. [MeSH]
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gawlik, I; Huang, HS; Müller, K; Prinz, H; Ziereis, K | 1 |
Breu, K; Müller, K; Reindl, H | 1 |
Müller, K; Wiegrebe, W | 1 |
Ehmann, CW; Lowe, N; Patel, BG; Wang, JC | 1 |
1 review(s) available for anthrone and Psoriasis
Article | Year |
---|---|
Treatment of psoriasis with anthrones-chemical principles, biochemical aspects, and approaches to the design of novel derivatives.
Topics: Anthracenes; Anthralin; Drug Design; Humans; Lipid Peroxidation; Lipoxygenase Inhibitors; Psoriasis; Reactive Oxygen Species | 1995 |
3 other study(ies) available for anthrone and Psoriasis
Article | Year |
---|---|
Simple analogues of anthralin: unusual specificity of structure and antiproliferative activity.
Topics: Administration, Topical; Animals; Anthralin; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Arachidonate 5-Lipoxygenase; Cattle; Cell Division; Humans; Keratinocytes; Leukocytes, Mononuclear; Lipoxygenase Inhibitors; Oxidants; Psoriasis; Sensitivity and Specificity; Structure-Activity Relationship | 1997 |
Antipsoriatic anthrones with modulated redox properties. 5. Potent inhibition of human keratinocyte growth, induction of keratinocyte differentiation, and reduced membrane damage by novel 10-arylacetyl-1,8-dihydroxy-9(10H)-anthracenones.
Topics: Acetanilides; Anthracenes; Anti-Inflammatory Agents, Non-Steroidal; Cell Differentiation; Cell Division; Cell Line; Cell Membrane; Humans; Keratinocytes; Leukotriene B4; Oxidation-Reduction; Psoriasis; Structure-Activity Relationship | 2001 |
The release and percutaneous permeation of anthralin products, using clinically involved and uninvolved psoriatic skin.
Topics: Anthracenes; Anthralin; Anthraquinones; Humans; In Vitro Techniques; Psoriasis; Skin Absorption | 1987 |